1. Home
  2. AZTA vs LENZ Comparison

AZTA vs LENZ Comparison

Compare AZTA & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • LENZ
  • Stock Information
  • Founded
  • AZTA 1978
  • LENZ 2019
  • Country
  • AZTA United States
  • LENZ United States
  • Employees
  • AZTA N/A
  • LENZ N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • LENZ Medicinal Chemicals and Botanical Products
  • Sector
  • AZTA Technology
  • LENZ Health Care
  • Exchange
  • AZTA Nasdaq
  • LENZ Nasdaq
  • Market Cap
  • AZTA 1.4B
  • LENZ 1.1B
  • IPO Year
  • AZTA 1995
  • LENZ 2021
  • Fundamental
  • Price
  • AZTA $29.94
  • LENZ $40.01
  • Analyst Decision
  • AZTA Buy
  • LENZ Strong Buy
  • Analyst Count
  • AZTA 4
  • LENZ 4
  • Target Price
  • AZTA $42.00
  • LENZ $49.75
  • AVG Volume (30 Days)
  • AZTA 456.3K
  • LENZ 436.9K
  • Earning Date
  • AZTA 11-11-2025
  • LENZ 11-05-2025
  • Dividend Yield
  • AZTA N/A
  • LENZ N/A
  • EPS Growth
  • AZTA N/A
  • LENZ N/A
  • EPS
  • AZTA N/A
  • LENZ N/A
  • Revenue
  • AZTA $668,821,000.00
  • LENZ $5,000,000.00
  • Revenue This Year
  • AZTA N/A
  • LENZ N/A
  • Revenue Next Year
  • AZTA $4.18
  • LENZ $258.37
  • P/E Ratio
  • AZTA N/A
  • LENZ N/A
  • Revenue Growth
  • AZTA 12.46
  • LENZ N/A
  • 52 Week Low
  • AZTA $23.91
  • LENZ $16.54
  • 52 Week High
  • AZTA $55.64
  • LENZ $42.77
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 48.40
  • LENZ 55.17
  • Support Level
  • AZTA $29.01
  • LENZ $39.62
  • Resistance Level
  • AZTA $31.38
  • LENZ $42.66
  • Average True Range (ATR)
  • AZTA 1.05
  • LENZ 1.97
  • MACD
  • AZTA 0.05
  • LENZ -0.12
  • Stochastic Oscillator
  • AZTA 48.57
  • LENZ 53.69

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: